BURZYKOWSKI, Tomasz

Email Alert RSS Feed

Profile

Full Name
BURZYKOWSKI, Tomasz
Email
tomasz.burzykowski@uhasselt.be
 
Loading... 5 0 5 0 false
Loading... 6 0 5 0 false

Publications

Refined By:
Date Issued:  [2010 TO 2019]
Author:  Saad, Everardo D.

Results 1-7 of 7 (Search time: 0.002 seconds).

Issue DateTitleContributor(s)TypeCat.
12019Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysisSaad, Everardo D.; Squifflet, Pierre; BURZYKOWSKI, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith; Piccart-Gebhart, Martine; Schneider, Bryan P.; Slamon, Dennis; Wolmark, Norman; BUYSE, MarcJournal ContributionA1
22019Chronological Trends in Progression-Free, Overall, and Post-Progression Survival in First-Line Therapy for Advanced NSCLCRutkowski, Jacek; Saad, Everardo D.; BURZYKOWSKI, Tomasz; BUYSE, Marc; Jassem, JacekJournal ContributionA1
32018The search for surrogate endpoints for immunotherapy trialsBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA2
42018Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?Saad, Everardo D.; Zalcberg, John R.; Peron, Julien; Coart, Elisabeth; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
52017Adoption of Pathologic Complete Response as a Surrogate End Point in Neoadjuvant Trials in HER2-Positive Breast Cancer Still an Open QuestionBURZYKOWSKI, Tomasz; Saad, Everardo D.; BUYSE, MarcJournal ContributionA1
62017Precision medicine needs randomized clinical trialsSaad, Everardo D.; PAOLETTI, Xavier; BURZYKOWSKI, Tomasz; BUYSE, MarcJournal ContributionA1
72016Neoadjuvant as Future for Drug Development in Breast Cancer-LetterBUYSE, Marc; BURZYKOWSKI, Tomasz; Saad, Everardo D.Journal ContributionA1